yup that is massive but its mainly first mover advantage. They launched their product first so got a head start to get market share.
this put this into context this why CB focused on the US.
But if my understanding is correct, Pylarify is not approved elsewhere while Iluccix is approved in canada, au and hopefully soon in EU.
this is good competition, I expect TLX to get market share assuming they continue to improve marketing, distribution and manufacturing. so yes, the next quarter report will be very interesting.
yup that is massive but its mainly first mover advantage. They...
-
- There are more pages in this discussion • 1,438 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.98 |
Change
-0.490(2.09%) |
Mkt cap ! $7.691B | |||
| Open | High | Low | Value | Volume |
| $23.25 | $23.36 | $22.78 | $32.40M | 1.409M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $22.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $22.99 | 421 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| TLX (ASX) Chart |